|
1N9U
Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Structure-Function Relationship
Deposited 2002-11-26
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
34–43(10 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
298 K;Pressure ambient
NMR sample composition
2.5 mM; DMSO-d6 | DMSO-d6
|
Resolution not provided
|
|
1N9V
Differences and Similarities in Solution Structures of Angiotensin I & II: Implication for Structure-Function Relationship.
Deposited 2002-11-26
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
34–41(8 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
298 K;Pressure ambient
NMR sample composition
2.5 mM; DMSO-d6 | DMSO-d6
|
Resolution not provided
|
|
2JP8
Angiotensin 1-7
Deposited 2007-04-27
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain P
34–40(7 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 2.9;278 K;Ionic strength (raw mmCIF value) 12;Pressure ambient
NMR sample composition
12.0 mM angiotensin, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided
|
|
2WXW
Crystal structure of human angiotensinogen
Deposited 2009-11-11
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
34–485(452 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;2-2.5N NACL, 0.2M CACL2, 0.1M TRIS-HCL, PH8
|
Resolution 3.30 Å
R-free 0.318
|
|
2X0B
Crystal structure of human angiotensinogen complexed with renin
Deposited 2009-12-08
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
34–485(452 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;1.6-2.2M AS, 0.1M MES, PH6
|
Resolution 4.33 Å
R-free 0.334
|
|
2X0B
Crystal structure of human angiotensinogen complexed with renin
Deposited 2009-12-08
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
34–485(452 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;1.6-2.2M AS, 0.1M MES, PH6
|
Resolution 4.33 Å
R-free 0.334
|
|
2X0B
Crystal structure of human angiotensinogen complexed with renin
Deposited 2009-12-08
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
34–485(452 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;1.6-2.2M AS, 0.1M MES, PH6
|
Resolution 4.33 Å
R-free 0.334
|
|
2X0B
Crystal structure of human angiotensinogen complexed with renin
Deposited 2009-12-08
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
34–485(452 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;1.6-2.2M AS, 0.1M MES, PH6
|
Resolution 4.33 Å
R-free 0.334
|
|
4AA1
Crystal structure of ANCE in complex with Angiotensin-II
Deposited 2011-11-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain P
34–41(8 aa)
|
Not recorded
|
ZN ZINC ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;0.1 M HEPES 7.5, 1.3 M SODIUM CITRATE
|
Resolution 1.99 Å
R-free 0.211
|
|
4APH
Human angiotensin-converting enzyme in complex with angiotensin-II
Deposited 2012-04-03
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain P
34–41(8 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
ZN ZINC ION × 1
PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
ACT ACETATE ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.7;50MM SODIUM ACETATE PH 4.7, 16% PEG4000, 10UM ZNSO4
|
Resolution 1.99 Å
R-free 0.240
|
|
4FYS
Human aminopeptidase N (CD13) in complex with angiotensin IV
Deposited 2012-07-05
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
36–41(6 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
SO4 SULFATE ION × 11
|
X-RAY DIFFRACTION
X-ray crystallization conditions
hanging drop vapor diffusion;pH 5;295 K;2M ammonium sulfate, 0.1M sodium acetate, 10% glycerol, pH 5.0, hanging drop vapor diffusion, temperature 295K
|
Resolution 2.01 Å
R-free 0.198
|
|
5M3X
Crystal structure of human angiotensin I-deleted angiotensinogen
Deposited 2016-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
44–485(442 aa)
|
Mutation:N137Q, N271Q, N295Q, C232S, C308S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;1.7M Ammonium Sulfate,
0.1M Citric Acid, pH3.6
|
Resolution 2.63 Å
R-free 0.282
|
|
5M3X
Crystal structure of human angiotensin I-deleted angiotensinogen
Deposited 2016-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
44–485(442 aa)
|
Mutation:N137Q, N271Q, N295Q, C232S, C308S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;1.7M Ammonium Sulfate,
0.1M Citric Acid, pH3.6
|
Resolution 2.63 Å
R-free 0.282
|
|
5M3Y
Crystal structure of human glycosylated angiotensinogen
Deposited 2016-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
34–485(452 aa)
|
Mutation:N137Q, N271Q, N295Q, C232S, C308S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;2.0M Ammonium Sulfate,
0.1M Bicine, pH9.0
|
Resolution 2.30 Å
R-free 0.189
|
|
6I3F
Crystal structure of the complex of human angiotensinogen and renin at 2.55 Angstrom
Deposited 2018-11-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
34–485(452 aa)
|
Mutation:N137Q, N271Q, N295Q,C232S,C308S
|
SO4 SULFATE ION × 10
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.6;293 K;1.76M Ammonium sulfate
0.1M Tris, pH7.6
|
Resolution 2.55 Å
R-free 0.234
|
|
6I3I
Crystal structure of reactive center loop (RCL) cleaved angiotensinogen
Deposited 2018-11-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
34–485(452 aa)
|
Mutation:N137Q,N271Q,N295Q,C232S,C308S
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;1.5M ammonium sulfate,
0.1M Tris pH8.5
12% glycerol
|
Resolution 2.97 Å
R-free 0.237
|
|
6OS0
Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to angiotensin II
Deposited 2019-05-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
34–41(8 aa)
Fragment:residues 34-41
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 7.6;293 K;Protein complex was reconstituted with a 10:1 (w/w) mixture of monoolein and cholesterol. Crystals were grown in 100 mM Tris pH 7.6, 10 mM MgCl2, 25-26% PEG 300
|
Resolution 2.90 Å
R-free 0.318
|